EBV: Clinical Trials

1 trial for EBV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Terminated 1

Follow EBV: new trials by email Literature Review of EBV trials Research Report on EBV

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
Nelfinavir - Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Early Phase 1TerminatedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins12014-07-012016-06-10

Narrower conditions

Castleman Disease (1)  ·  Hodgkin Disease (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Nasopharyngeal Neoplasms (1)  ·  Neoplasms (1)  ·  Sarcoma (1)  ·  Sarcoma, Kaposi (1)  ·  Stomach Neoplasms (1)

Broader conditions

DNA Virus Infections (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Nasopharyngeal Diseases (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Nelfinavir (1)

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Countries

United States (1)

Top investigators

Richard Ambinder, MD (1)